Tatva Chintan Pharma Chem Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	113.74	353.04	273.65	630.17	44.81
Short-Term Investments	-	3.27	3.13	138.5	8.02	8.43
Trading Asset Securities	-	-	100.51	-	-	-
Cash & Short-Term Investments	171.72	117.01	456.68	412.15	638.19	53.24
Cash Growth	15.46%	-74.38%	10.80%	-35.42%	1098.70%	-55.34%
Accounts Receivable	-	895.49	720.24	875.03	584.27	907.43
Other Receivables	-	11.9	5.18	3.21	27.21	24.95
Receivables	-	909.76	727.83	879.96	613.09	933.57
Inventory	-	1,340	1,528	1,625	1,700	720.19
Prepaid Expenses	-	49.29	55.84	37.1	21.22	15.09
Other Current Assets	-	236.85	211.05	168.31	1,384	120.41
Total Current Assets	-	2,652	2,979	3,123	4,356	1,843
Property, Plant & Equipment	-	5,471	4,995	4,265	2,108	1,302
Other Intangible Assets	-	58.99	39.61	4.76	3.17	0.95
Long-Term Deferred Tax Assets	-	126.24	122.97	164.03	87.1	-
Other Long-Term Assets	-	53.94	50.92	32.13	26.02	2.96
Total Assets	-	8,362	8,187	7,589	6,581	3,148
Accounts Payable	-	326.89	450.31	321.88	445.13	474.77
Accrued Expenses	-	123.39	87.97	67.46	75.75	60
Short-Term Debt	-	357.49	100	1,562	924.69	492.94
Current Portion of Long-Term Debt	-	6.39	36.32	98.18	143.58	141.91
Current Income Taxes Payable	-	20.16	0.76	2.13	10.23	3.93
Current Unearned Revenue	-	70.22	21.72	33.12	18.38	0.09
Other Current Liabilities	-	55.73	99.55	302.05	94.2	6.51
Total Current Liabilities	-	960.27	796.63	2,387	1,712	1,180
Long-Term Debt	-	-	6.39	42.3	131.11	267.63
Long-Term Unearned Revenue	-	-	-	-	0.08	0.17
Long-Term Deferred Tax Liabilities	-	-	-	-	-	20.78
Other Long-Term Liabilities	-	13.98	13.34	11.45	6.51	19.66
Total Liabilities	-	974.25	816.36	2,441	1,850	1,488
Common Stock	-	233.92	233.92	221.65	221.65	200.88
Additional Paid-In Capital	-	4,044	4,044	2,090	2,090	-
Retained Earnings	-	3,085	3,077	2,825	2,415	1,456
Comprehensive Income & Other	-	25.08	15.84	10.75	4.27	2.74
Shareholders' Equity	7,544	7,388	7,371	5,148	4,731	1,660
Total Liabilities & Equity	-	8,362	8,187	7,589	6,581	3,148
Total Debt	830.13	363.88	142.71	1,703	1,199	902.48
Net Cash (Debt)	-658.41	-246.87	313.97	-1,290	-561.19	-849.24
Net Cash Per Share	-28.17	-10.55	13.72	-58.22	-26.10	-42.28
Filing Date Shares Outstanding	23.37	23.39	23.39	22.17	22.17	20.09
Total Common Shares Outstanding	23.37	23.39	23.39	22.17	22.17	20.09
Working Capital	-	1,692	2,182	735.59	2,644	662.35
Book Value Per Share	322.54	315.84	315.10	232.25	213.44	82.62
Tangible Book Value	7,479	7,329	7,331	5,143	4,728	1,659
Tangible Book Value Per Share	319.77	313.32	313.41	232.04	213.30	82.57
Buildings	-	1,698	1,544	504.8	376.53	374.45
Machinery	-	4,107	3,005	1,478	1,153	883.5
Construction In Progress	-	215.35	729.27	2,307	514.91	98.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.